As coverage expands and demand grows, better data and evidence will be essential to ensuring these therapies are used where they offer the most value for patients and the healthcare system overall
The drug or matching placebo were given for 12 months and the primary endpoint, as shown below, was a motor score used by neurologists (Movement Disorder Scale-Unified Parkinsons Disease Rating Scale) MDS-UPDRS Part III)
L - carnitine tartrate, Green tea leaf extract (Camellia sinensis L.) standardized to 50% polyphenols, Guarana seed extract (Paullinia cupana Kunth) standardized to 22% caffeine, Green coffee bean extract (Coffea Arabica L.) standardized to 50% chlorogenic acid and 5% caffeine, Extract from the above-ground parts of horsetail (Equisetum arvense L.) standardized to 7% silica, Grape seed extract (Vitis vinifera L.) standardized to 95% proanthocyanidins (PAC), Licorice root extract (Glycyrrhiza glabra L.) standardized to 20% glycyrrhizinic acid, anti-caking agent: magnesium salts of fatty acids
Funding This study was supported by National High Level Hospital Clinical Research Funding (NO
A steady state in plasma concentrations is achieved after four once-weekly injections
References Kommu S., & Whitfield P
